Fig 1: Protein carbonylation levels in different tissues induced or not with LPS. Protein carbonylation by 2,4-dinitrophenylhydrazine was determined by AbCam’s ab126287 commercial kit as a measure of protein irreversible oxidative damage in the liver, brain, and gastrocnemius muscle homogenates collected from n = 5 (outliers removed) 8-month-old C57Bl mice. The results (outliers removed) show that LPS-induced protein oxidation, which was attenuated by ATX, was significantly further attenuated by LDS-AXT in the liver, attenuated to the same extent by ATX and LDS-ATX in the brain, and attenuated only by LDS-AXT (p < 0.08) and not by AXT in the muscle. Basal, non-induced lipid peroxidation was not significantly affected by LDS-ATX. LDS-ATX inhibited protein carbonylation in LPS-induced animals only as a trend (p < 0.08). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. One-way ANOVA with Fisher’s post hoc test.
Supplier Page from Abcam for Protein Carbonyl Content Assay Kit